Natoli et al. [45] showed that 90K greatly promoted immune reaction in breast cancer by inducing IL-2 and MHC I. In our study, 90K was also found to have a close correlation with DC-specific marker genes, which may be used as an antigen for the DC vaccine. Here, IL2 is linked to breast carcinoma.